Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim A Papp

Showing results (1-10 of 219) with videos related to

Pageof 22
Sort By:
Therapeutics and Clinical Risk Management|March 25, 2008
The safety of etanercept for the treatment of plaque psoriasisKim A Papp
Drugs of Today (Barcelona, Spain : 1998)|January 13, 2005
Efalizumab: Advancing psoriasis management with a novel, targeted T-cell modulatorKim A Papp
Expert Opinion on Pharmacotherapy|October 6, 2004
Etanercept in psoriasisKim A Papp
Archives of Dermatological Research|May 13, 2006
The long-term efficacy and safety of new biological therapies for psoriasisKim A Papp
Clinics in Dermatology|August 30, 2008
Monitoring biologics for the treatment of psoriasisKim A Papp
Journal of Cutaneous Medicine and Surgery|May 22, 2010
Psoriasis care: new and emerging pharmacologic trendsKim A Papp, Wayne Carey
Journal of Drugs in Dermatology : JDD|June 24, 2020
Safety surveillance for ustekinumab and other psoriasis treatments from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) ErrataKim A Papp, Wayne Langholff
Journal of Cutaneous Medicine and Surgery|May 16, 2006
Safe psoriasis control: a new outcome measure for the composite assessment of the efficacy and safety of psoriasis treatmentKim A Papp, Eric Henninger
BMC Dermatology|September 21, 2006
Evaluation of efalizumab using safe psoriasis controlKim A Papp, Eric Henninger
Journal of Drugs in Dermatology : JDD|March 15, 2018
Onset of Action of Biologics in Patients With Moderate-to-Severe PsoriasisKim A Papp, Mark G Lebwohl
Pageof 22

Showing results (1-10 of 219) with videos related to

Sort By:
Pageof 22
Therapeutics and Clinical Risk Management|March 25, 2008
The safety of etanercept for the treatment of plaque psoriasisKim A Papp
Drugs of Today (Barcelona, Spain : 1998)|January 13, 2005
Efalizumab: Advancing psoriasis management with a novel, targeted T-cell modulatorKim A Papp
Expert Opinion on Pharmacotherapy|October 6, 2004
Etanercept in psoriasisKim A Papp
Archives of Dermatological Research|May 13, 2006
The long-term efficacy and safety of new biological therapies for psoriasisKim A Papp
Clinics in Dermatology|August 30, 2008
Monitoring biologics for the treatment of psoriasisKim A Papp
Journal of Cutaneous Medicine and Surgery|May 22, 2010
Psoriasis care: new and emerging pharmacologic trendsKim A Papp, Wayne Carey
Journal of Drugs in Dermatology : JDD|June 24, 2020
Safety surveillance for ustekinumab and other psoriasis treatments from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) ErrataKim A Papp, Wayne Langholff
Journal of Cutaneous Medicine and Surgery|May 16, 2006
Safe psoriasis control: a new outcome measure for the composite assessment of the efficacy and safety of psoriasis treatmentKim A Papp, Eric Henninger
BMC Dermatology|September 21, 2006
Evaluation of efalizumab using safe psoriasis controlKim A Papp, Eric Henninger
Journal of Drugs in Dermatology : JDD|March 15, 2018
Onset of Action of Biologics in Patients With Moderate-to-Severe PsoriasisKim A Papp, Mark G Lebwohl
Pageof 22